According to these authors, NF-κB was undetectable in control group breast tissue patients, whereas activation of NF-κB was significantly correlated with high grade, large tumor size, high NPI value, ER negativity, PR negativity and HER-2/neu positivity in breast cancer patients. Here, ESR1 is linked to breast cancer.